13F Data
13F filer · CIK 1658437

Puissance Capital Management LP

NEW YORK, NY · filing since Q4 2017 · last filing Nov 12, 2020
Reported value
$17.3M
$-6.1M vs prior
Positions
5
New / sold out
2 / 1
Added / reduced
0 / 0
Turnover
8.7%
buys $1.8M · sells $2.3M
Top-10 weight
100.0%

Biggest buys vs Q2 2020

ChangeSecurityShares changeChange %Est. trade value
NewSCYNEXIS INC+311,143–+$1.4M
NewKADMON HLDGS INC+100,184–+$393.0K

Biggest sells vs Q2 2020

ChangeSecurityShares changeChange %Est. trade value
Sold outSCYNEXIS INC-3,111,436-100.0%$-2.3M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2017: $144.8MQ1 2018: $116.0MQ2 2018: $133.0MQ3 2018: $143.3MQ4 2018: $87.7MQ1 2019: $123.0MQ2 2019: $102.2MQ3 2019: $44.8MQ4 2019: $40.3MQ1 2020: $8.6MQ2 2020: $23.4MQ3 2020: $17.3M
Q4 2017Q3 2020

Holdings · Q3 2020

#SecuritySharesValueWeight
1BELLEROPHON THERAPEUTICS INCCOM NEW1,153,846$11.7M67.74%
2EKSO BIONICS HLDGS INCCOM774,400$3.7M21.21%
3SCYNEXIS INCCOM NEW311,143$1.4M7.91%
4KADMON HLDGS INCCOM100,184$393.0K2.27%
5CORVUS PHARMACEUTICALS INCCOM38,010$152.0K0.88%